Abstract
The objective of the study is to evaluate the clinical and neuroradiological findings, the risk factors for recurrence and the prognosis in patients with posterior reversible encephalopathy syndrome developed secondary to acute hypertension in children. The study was conducted between 2008 and 2019 at Mersin University Faculty of Medicine. A total of 49 episodes were evaluated retrospectively in 38 patients with PRES secondary to acute hypertension. The demographic data, etiology, and clinical and neuroradiological findings were recorded. Twenty-one (55.3%) patients were female; the mean age was 11.8 years. The etiology of acute hypertension in 29 (76.3%) patients was end-stage renal disease (ESRD). The most common clinical findings were seizure (81.6%) and altered consciousness (79.6%). Status epilepticus developed in eight (16.3%) episodes. MRI lesions were atypical in 33 episodes (67.3%). In eight (21%) patients, PRES recurred. Irreversible brain damage was detected after PRES in three (7.8%) patients. C-reactive protein and erythrocyte sedimentation rate were elevated in 82.2% and 71.4% of the episodes, respectively. A statistically significant relationship was found between the recurrence, the duration of hospitalization at the PICU, SE and the occurrence of irreversible lesion (p = 0.013, p = 0.015, p = 0.001 respectively). Also, there were statistically significant relationships between recurrence and ESRD; epilepsy and recurrences; SE and irreversible brain damage (p = 0.02, p = 0.012, p = 0.025 respectively). Although PRES is usually known to have a good prognosis, the mortality and morbidity rates may increase in the long-term follow-up as in our study. In this study, the etiology, the presence of status epilepticus, PICU history, atypical MRI lesions and increased inflammatory markers were found to be important for the prognosis in PRES.
Similar content being viewed by others
References
Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500
Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925
Rabinstein AA, Mandrekar J, Merrell R, Kozak OS, Durosaro O, Fugate JE (2012) Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 21:254–258
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432
Tetsuka S, Ogawa T (2019) Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics. J Neurol Sci 404:72–79
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576
Onder AM, Lopez R, Teomete U et al (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22:1921–1929
Yamada A, Ueda N (2012) Age and gender may affect posterior reversible encephalopathy syndrome in renal disease. Pediatr Nephrol 27:277–283
Yamamoto H, Natsume J, Kidokoro H et al (2015) Clinical and neuroimaging findings in children with posterior reversible encephalopathy syndrome. Eur J Paediatr Neurol 19:672–678
Gupta V, Bhatia V, Khandelwal N, Singh P, Singhi P (2016) Imaging Findings in Pediatric Posterior Reversible Encephalopathy Syndrome (PRES): 5 years of experience from a Tertiary Care Center in India. J Child Neurol 31:1166–1173
Lamy C, Oppenheim C, Mas JL (2014) Posterior reversible encephalopathy syndrome. Handb Clin Neurol 121:1687–1701
Li R, Mitchell P, Dowling R, Yan B (2013) Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome? J Clin Neurosci 20:248–252
Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E (2012) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 259:155–164
Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69:894–897
Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65:205–210
Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320–1327
Habetz K, Ramakrishnaiah R, Raina SK, Fitzgerald RT, Hinduja A (2016) Posterior reversible encephalopathy syndrome: a comparative study of pediatric versus adult patients. Pediatr Neurol 65:45–51
Gavrilovici C, Miron I, Voroneanu L, Bădărau S, Stârcea M (2017) Posterior reversible encephalopathy syndrome in children with kidney disease. Int Urol Nephrol 49:1793–1800
Morris EB, Laningham FH, Sandlund JT, Khan RB (2007) Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152–159
Chen TH, Lin WC, Tseng YH, Tseng CM, Chang TT, Lin TJ (2013) Posterior reversible encephalopathy syndrome in children: case series and systematic review. J Child Neurol 28:1378–1386
Kamiya-Matsuoka C, Paker AM, Chi L, Youssef A, Tummala S, Loghin ME (2016) Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study. J Neurooncol 128:75–84
Heo K, Cho KH, Lee MK, Chung SJ, Cho YJ, Lee BI (2016) Development of epilepsy after posterior reversible encephalopathy syndrome. Seizure 34:90–94
Khan RB, Sadighi ZS, Zabrowski J, Gajjar A, Jeha S (2016) Imaging patterns and outcome of posterior reversible encephalopathy syndrome during childhood cancer treatment. Pediatr Blood Cancer 63:523–526
Komur M, Delibas A, Arslankoylu AE, Okuyaz C, Kara E (2012) Recurrent and atypical posterior reversible encephalopathy syndrome in a child with hypertension. Ann Indian Acad Neurol 15:208–210
Sweany JM, Bartynski WS, Boardman JF (2007) “Recurrent” posterior reversible encephalopathy syndrome: report of 3 cases–PRES can strike twice! J Comput Assist Tomogr 31:148–156
Donmez FY, Agildere AM (2015) Recurrent childhood PRES. Neurol Sci 36:1603–1609
Siebert E, Bohner G, Liebig T, Endres M, Liman TG (2017) Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol 264:237–242
Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 27:2179–2190
Hinduja A, Habetz K, Raina S, Ramakrishnaiah R, Fitzgerald RT (2017) Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci 127:135–144
Liman TG, Bohner G, Endres M, Siebert E (2014) Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand 130:34–39
Funding
Nil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Komur, M., Ozgur, A., Delibas, A. et al. Posterior reversible encephalopathy syndrome (PRES) due to acute hypertension in children: 12 years single-center experience. Acta Neurol Belg 121, 1583–1589 (2021). https://doi.org/10.1007/s13760-020-01423-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-020-01423-1